Skip to main content
. 2023 Mar 29;54(5):2040–2054. doi: 10.1007/s10803-023-05963-2

Table 1.

Demographic data statistics of autistic and neurotypical participants

Quantitative survey autistic N = 52 Quantitative survey non-autistic N = 195 Qualitative interview autistic N = 14
N % N % N %
Age mean years (SD) 38.19 (14.3) 31.21 (54.7) 40.5 (16.5)
Gender
 Male 21 40.4 52 26.7 9 64.3
 Female 29 55.8 142 72.8 4 28.6
 Non-Binary 2 3.9 1 0.5 1 7.1
Diagnosis
 Confirmed 50 96.2 - - 13 92.9
 Self-diagnosed 2 3,9 - - 1 7.1
Diagnosis Type
 Autism Spectrum Conditions 29 58 - - 8 57.1
 Autistic Disorder 3 6.0 - -
 Asperger’s Disorder 18 36 6 42.9
Psychiatric Conditions*
 Anxiety disorders 16 30.8 14 7.2 8 57.1
 Depressive disorders 17 32.7 12 6.2 8 57.1
 Trauma- and stressor-related disorders 7 13.5 0 0 2 14.3
 Other neurodevelopmental conditions (e.g., ADHD) 3 5.8 5 2.6 1 7.1
 Obsessive–compulsive and related disorders 2 3.8 2 1.0 1 7.1
 Feeding and eating disorders 1 1.9 1 0.5 0 0
 Schizophrenia spectrum and other psychotic disorders 1 1.9 0 0 0 0
Medications for psychiatric conditions
 SSRIs 8 15.4 6 3.1 2 14.3
 Tricyclic antidepressants 6 11.5 0 0 1 7.1
 SNRIs 6 11.5 0 0 1 7.1
 Mood stabilizers 1 1.9 0 0 0 0
 Antidepressants unspecified 3 5.8 3 1.5 1 7.1
 Anti-anxiety agents 4 7.7 0 0 3 21.4
 Anxiety unspecified 2 3.8 0 0 0 0
 Stimulants 2 3.8 3 1.5 0 0
 ADHD unspecified 1 1.9 0 0 0 0
 Antipsychotic unspecified 1 1.9 0 0 0 0
 Atypical antipsychotics 1 1.9 1 0.5 2 14.3

ADHD Attention Deficit Hyperactivity Disorder, SD Standard Deviation, SSRI Selective serotonin reuptake inhibitor antidepressants, SNRIs Serotonin-norepinephrine reuptake inhibitor antidepressants

*Conditions as self-reported by participants, categorized according to DSM-5